急诊上消化道出血患者预后评分评估
该研究先系统检索文献识别现有预后评分,再用多中心回顾性队列纳入2019年1月1日至2020年12月31日因上消化道出血住院的成人患者,评估各评分预测7天内治疗干预(输血、内镜、手术或介入放射止血)和/或30天死亡复合结局的能力。共识别39个预后评分,其中12个可分析;990例患者中755例(76.4%)发生治疗干预和/或死亡。区分度最佳为GBS(AUC 0.869 [0.842至0.895])、改良GBS(AUC 0.872 [0.847至0.898])和改良GBS 2(AUC 0.855 [0.827至0.884]);识别低危患者最佳为GBS≤1(敏感性0.99 [0.99至1.00],NPV 0.89 [0.75至0.97])和改良GBS=0(敏感性0.99 [0.98至1.00],NPV 0.84 [0.71至0.94])。作者认为GBS和改良GBS因同时实现风险分层和识别可门诊管理的低危患者两个关键目标而表现最佳。
要点
- 990例上消化道出血住院成人中,治疗干预和/或死亡复合结局发生755例(76.4%)。
- 预测复合结局的区分度:GBS的AUC 0.869(0.842至0.895),改良GBS的AUC 0.872(0.847至0.898),改良GBS 2的AUC 0.855(0.827至0.884)。
- 识别低危患者:GBS≤1敏感性0.99(0.99至1.00)、NPV 0.89(0.75至0.97);改良GBS=0敏感性0.99(0.98至1.00)、NPV 0.84(0.71至0.94)。
- 系统检索共识别39个上消化道出血预后评分,其中12个可纳入分析。
- 作者认为GBS和改良GBS是表现最好的2个评分,因同时实现风险分层和识别可能符合门诊管理的低危患者。
适用人群与场景
- 2019年1月1日至2020年12月31日因上消化道出血住院的成人患者,来自多中心回顾性队列。
诊断标准与关键阈值
- GBS≤1用于识别低危患者:敏感性0.99(0.99至1.00),阴性预测值0.89(0.75至0.97)。
- 改良GBS=0用于识别低危患者:敏感性0.99(0.98至1.00),阴性预测值0.84(0.71至0.94)。
研究设计与关键结果
- 研究类型:多中心回顾性队列研究,纳入990例因上消化道出血住院的成人患者。
- 主要复合结局为7天内治疗干预(输血、内镜、手术或介入放射止血)和/或30天死亡,发生755例(76.4%)。
- 预测主要复合结局的区分度:GBS的AUC 0.869(0.842至0.895),改良GBS的AUC 0.872(0.847至0.898),改良GBS 2的AUC 0.855(0.827至0.884)。
- 识别低危患者:GBS≤1敏感性0.99(0.99至1.00)、NPV 0.89(0.75至0.97);改良GBS=0敏感性0.99(0.98至1.00)、NPV 0.84(0.71至0.94)。
- 系统检索识别39个预后评分,其中12个可分析。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为GBS和改良GBS是表现最好的2个评分,因同时实现风险分层和识别可能符合门诊管理的低危患者两个关键目标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: Early prognostic stratification could optimize the management of patients with upper gastrointestinal bleeding and reduce unnecessary hospitalizations. The aim of this study was to assess and compare the performance of existing prognostic scores in predicting therapeutic intervention and death.
METHODS: A systematic search of the literature identified existing prognostic scores. A multicenter retrospective cohort study included adult patients hospitalized for upper gastrointestinal bleeding from January 1, 2019, to December 31, 2020. The primary outcome was a composite including therapeutic intervention within 7 days (blood transfusion, endoscopic, surgical, or interventional radiology hemostasis) and/or 30-day death. Discrimination performance was estimated by the area under the curve (AUC). The ability to identify low-risk patients was analyzed using sensitivity and negative predictive value (NPV) for defined thresholds.
RESULTS: The systematic search identified 39 prognostic scores, 12 of which could be analyzed. Among the 990 patients included, therapeutic intervention and/or death occurred in 755 (76.4%) patients. Scores with the highest discriminative performance to predict the primary composite outcome were Glasgow-Blatchford score (GBS) (AUC 0.869 [0.842 to 0.895]), modified GBS (AUC 0.872 [0.847 to 0.898]) and modified GBS 2 (AUC 0.855 [0.827 to 0.884]). The best performance to identify low-risk patients was for GBS≤1 (sensitivity 0.99 [0.99 to 1.00], NPV 0.89 [0.75 to 0.97]) and modified GBS=0 (sensitivity 0.99 [0.98 to 1.00], NPV 0.84 [0.71 to 0.94]).
CONCLUSIONS: The GBS and the modified GBS are the 2 best performing scores because they achieve both key objectives: stratifying patients based on their risk of therapeutic intervention and/or death and identifying low-risk patients who may qualify for outpatient management.
参考来源
- Thiebaud PC, Wassermann E, de Caluwe M, et al. Assessment of Prognostic Scores for Emergency Department Patients With Upper Gastrointestinal Bleeding. Ann Emerg Med. 2024. PMID: 39093247. doi:10.1016/j.annemergmed.2024.06.024
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。